Literature DB >> 30825116

Network Analysis of Depression-Related Transcriptomic Profiles.

Xiao Miao1,2, Bin Fan3, Rongqun Li4, Shaoping Zhang5, Honghuang Lin6.   

Abstract

Major depressive disorder is a common debilitating disorder that is associated with increased morbidity and mortality. However, the molecular mechanism underlying depression remains largely unknown. The current study investigated the association of depression with blood gene expression using data from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Depression was measured by the geriatric depression scale, and the blood gene expression was measured by the Affymetrix Human Genome U219 Array. Linear regression was used to test the association between gene expression and depression, and the model was adjusted for age and sex. A total of 671 participants were included in our study (mean age 75 ± 8 years, 43.2% women). We found three genes were associated with depression, including COL1A2 (P = 8.9 × 10-8), RNF150 (P = 1.4 × 10-7) and CTGF (P = 8.3 × 10-7). An interaction network was built, and the pathway analysis indicated that many depression-related genes were involved in the neurotrophin signaling pathway (P = 2.1 × 10-7). Future studies are necessary to validate our findings and further investigate potential mechanism of depression.

Entities:  

Keywords:  Depression; Gene expression; Interaction network

Mesh:

Substances:

Year:  2019        PMID: 30825116     DOI: 10.1007/s12017-019-08527-9

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  43 in total

1.  Genetic epidemiology of major depression: review and meta-analysis.

Authors:  P F Sullivan; M C Neale; K S Kendler
Journal:  Am J Psychiatry       Date:  2000-10       Impact factor: 18.112

2.  Discovering regulatory and signalling circuits in molecular interaction networks.

Authors:  Trey Ideker; Owen Ozier; Benno Schwikowski; Andrew F Siegel
Journal:  Bioinformatics       Date:  2002       Impact factor: 6.937

3.  Age at onset and familial risk for major depression in a Swedish national twin sample.

Authors:  Kenneth S Kendler; Margaret Gatz; Charles O Gardner; Nancy L Pedersen
Journal:  Psychol Med       Date:  2005-11       Impact factor: 7.723

4.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

5.  Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome.

Authors:  A Zimprich; M Grabowski; F Asmus; M Naumann; D Berg; M Bertram; K Scheidtmann; P Kern; J Winkelmann; B Müller-Myhsok; L Riedel; M Bauer; T Müller; M Castro; T Meitinger; T M Strom; T Gasser
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

Review 6.  Psychological autopsy studies of suicide: a systematic review.

Authors:  J T O Cavanagh; A J Carson; M Sharpe; S M Lawrie
Journal:  Psychol Med       Date:  2003-04       Impact factor: 7.723

7.  Cardiff depression study. A sib-pair study of life events and familiality in major depression.

Authors:  A Farmer; T Harris; K Redman; S Sadler; A Mahmood; P McGuffin
Journal:  Br J Psychiatry       Date:  2000-02       Impact factor: 9.319

8.  Genetic heterogeneity in ten families with myoclonus-dystonia.

Authors:  B Schüle; N Kock; M Svetel; N Dragasevic; K Hedrich; P De Carvalho Aguiar; L Liu; K Kabakci; J Garrels; E-M Meyer; I Berisavac; E Schwinger; P L Kramer; L J Ozelius; C Klein; V Kostic
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

Review 9.  Prevalence and incidence studies of mood disorders: a systematic review of the literature.

Authors:  Paul Waraich; Elliot M Goldner; Julian M Somers; Lorena Hsu
Journal:  Can J Psychiatry       Date:  2004-02       Impact factor: 4.356

10.  Prevalence and correlates of DSM-IV major depression in an Australian national survey.

Authors:  Kay Wilhelm; Philip Mitchell; Tim Slade; Suzanne Brownhill; Gavin Andrews
Journal:  J Affect Disord       Date:  2003-07       Impact factor: 4.839

View more
  2 in total

Review 1.  Multifunctional regulatory protein connective tissue growth factor (CTGF): A potential therapeutic target for diverse diseases.

Authors:  Minyang Fu; Dandan Peng; Tianxia Lan; Yuquan Wei; Xiawei Wei
Journal:  Acta Pharm Sin B       Date:  2022-01-19       Impact factor: 14.903

2.  Venlafaxine Inhibits the Apoptosis of SHSY-5Y Cells Through Active Wnt/β-Catenin Signaling Pathway.

Authors:  Ruijie Geng; Haibin Li; Hao Wang; Chenyu Ye; Yemeng Mao; Xiao Huang
Journal:  Neuropsychiatr Dis Treat       Date:  2021-04-21       Impact factor: 2.570

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.